Vera Therapeutics Inc. has announced new compensation terms under its Inducement Plan, following the grant of inducement awards by the company's Compensation Committee on July 6, 2025. These awards include non-qualified stock options for 133,500 shares of Class A common stock, with an exercise price of $24.00 per share, and restricted stock units (RSUs) for 73,695 shares. The stock options will vest over four years, with 25% vesting one year after the vesting commencement date, and the remainder vesting monthly over the next 36 months. The RSUs will also vest over four years, with 25% vesting annually starting from August 20, 2025. These grants, made in accordance with Nasdaq Listing Rule 5635(c)(4), are part of the company's efforts to attract new talent.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.